User Manual Part 2

C-14
CLINICAL STUDY - MADIT II
inhibitors, beta blockers, or digitalis therapy between the ICD therapy group
and the conventional therapy patients.
Table C-5. Patient population medication therapy
Medication
ICD Patients
(n = 742)
Conventional Therapy
Patients
(n = 490)
p-value
ACE inhibitor use (patients, %)
Baseline/Enrollment 574 (77.4%) 377 (76.9%)
0.47
Last F ollow-up
533 (71.8%) 363 (7 4.1%)
0.31
Amiodarone use (patients, %)
Baseline/Enrollment 49 (6.6%) 36 (7.3%)
0.41
Last F ollow-up
94 (12.7) 51 (10.4%)
0.23
Antiarrhythmic use (patients, %)
Baseline/Enrollment 18 (2.4%) 15 (3.1%)
0.37
Last F ollow-up
21 (2.8%) 12 (2.4%)
0.43
Aspirin use (patients, %)
Baseline/Enrollment 503 (67.8%) 344 (70.2%)
0.30
Last F ollow-up
477 (64.3%) 332 (6 7.8%)
0.20
Beta blocker use (p atie nts, %)
Baseline/Enrollment 469 (63.2%) 295 (60.2%)
0.28
Last F ollow-up
529 (71.3%) 351 (7 1.6%)
0.46
Digitalis use (patients, %)
Baseline/Enrollment 441 (59.4%) 277 (56.5%)
0.29
Last F ollow-up
451 (60.8%) 290 (5 9.2%)
0.41
Diuretics use (pa tients, %)
Baseline/Enrollment 541 (72.9%) 379 (77.3%)
0.09
Last F ollow-up
562 (75.7%) 396 (8 0.8%)
0.04
Lipid Lowering use (patients, %)
Baseline/Enrollment 492 (66.3%) 315 (64.3%)
0.37
Last F ollow-up
556 (74.9%) 339 (6 9.2%)
0.04
Sotalol use (patients, %)
- DRAFT -